Evolent Health (EVH) shares rose 3% in Tuesday trading after Citigroup upgraded the stock to buy from neutral and adjusted its price target to $6 from $6.75.
Trading volume stood at 2.6 million shares, compared with a daily average of 3 million.
Price: $4.05, Change: $+0.12, Percent Change: +3.05%